RSSCategory: General Healthcare News

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary H&E diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Guest Post: AI vs MD – What it Means for Pathology

AI vs MD: What it means for Pathology By David West, CEO, Proscia Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human doctors against computers. It’s a beautifully composed summary on the role of software algorithms in healthcare, examining […]

Continue Reading

A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1

| April 3, 2017 | 3 Comments

A loyal reader tipped me off to a recent article in The New Yorker entitled “A.I. Versus M.D.” The article is written by Dr. Siddhartha Mukherjee, a well known oncologist and author of The Emperor of all Maladies. This article, the book and the documentary are all worth reading/viewing if you are not familiar with […]

Continue Reading

ProNet Expands Use of Patient Data in Telehealth

| April 2, 2017 | 0 Comments

Telehealth is fundamentally changing how healthcare leaders handle care delivery. In the ever-changing digital age, it’s important to stay current on telehealth as to not fall behind the competition and more importantly, to provide a higher level of care to patients and work toward improved interoperability within the healthcare system. XIFIN is one of seven […]

Continue Reading

“Academic” Tweeting – Is it “Academic” and Will it Be Recognized as Such?

| March 23, 2017 | 2 Comments

Dr. Bruce Friedman over at Lab Soft News has an interesting post today on “The “Why” and “How” of Academic Tweeting”. Many of you know that Bruce is widely considered the grandfather of pathology informatics, coining the term decades ago, envisioning organizations, societies, fellowships before many. He and Mike Becich are two people I would […]

Continue Reading

The Restaurateur Who Thought Like a Pathologist

| March 21, 2017 | 0 Comments

Again, the talk of not healthcare reform but rather healthcare payment reform and the interests of lawmakers, physicians, patients, payers and industry at stake with potential significant cost/reimbursement and research budget cuts proposed has led me to thinking, without politicizing, how bizarre it all really can be. My first year of medical school a friend and I […]

Continue Reading

Adoption of Digital Pathology, Ford Model T and Electric Toothbrushes

| March 19, 2017 | 0 Comments

By Simon Häger, Product manager Sectra Digital Pathology Many pathology labs are currently switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. This transition is particularly strong in the Scandinavian countries and the Netherlands. It is highly likely that most labs throughout these regions will be completely digital within […]

Continue Reading

Leveraging Technology For Integrated Diagnostic Reporting

| March 9, 2017 | 0 Comments

By Chrystal Adams, Associate Vice President, XIFIN and Don Rule, CEO, Translational Software There is ongoing effort in healthcare to integrate and expand the use of patient data to improve clinical decision making and support cost-effective, patient-centered care. Much of the needed data resides within the diagnostic specialties of pathology, radiology, laboratory, and molecular diagnostics. […]

Continue Reading

‘Crosswalk’ Re-Launched to Make it Easier to Bridge the Gap Between Pathology, Precision Diagnosis and Precision Medicine

| February 20, 2017 | 1 Comment

Inspirata has just released new mobile and Web-based versions of “Crosswalk Insight: Oncology™,” a knowledge visualization platform that enables users to easily navigate through tumor images and the associated molecular pathways, targeted therapies and clinical trials. San Francisco, CA, February 20, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today the re-launch […]

Continue Reading